Celularity Inc
NASDAQ:CELU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celularity Inc
NASDAQ:CELU
|
US |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
Arvind Ltd
NSE:ARVIND
|
IN |
|
L
|
LPKF Laser & Electronics AG
OTC:LPKFF
|
DE |
|
B
|
Bimobject AB
STO:BIM
|
SE |
|
Energy Transfer LP
NYSE:ET
|
US |
|
Americold Realty Trust
NYSE:COLD
|
US |
|
A
|
Aurubis AG
XMUN:NDA
|
DE |
|
Yangarra Resources Ltd
TSX:YGR
|
CA |
|
F
|
Fifth Third Bancorp
SWB:FFH
|
US |
|
A
|
Aluminum Corporation of China Ltd
XMUN:AOC
|
CN |
|
D
|
Darden Restaurants Inc
XMUN:DDN
|
US |
|
Bollore SE
PAR:BOL
|
FR |
|
V
|
Volkswagen AG
F:VOW
|
DE |
|
Mattel Inc
NASDAQ:MAT
|
US |
|
L
|
L'Oreal SA
DUS:LOR
|
FR |
|
Latham Group Inc
NASDAQ:SWIM
|
US |
|
C
|
Coya Therapeutics Inc
NASDAQ:COYA
|
US |
Bankruptcy Probability
Celularity Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celularity Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celularity Inc
NASDAQ:CELU
|
30.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celularity Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celularity Inc has total debt of 34.2m USD. This includes both short-term (0 USD) and long-term (34.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
